25 August 2021
H2020 – JTI IMI 2 – 23nd Call for proposals – 2020
To improve the drug development process by supporting more efficient research and development cooperation among academia, SMEs and the biopharmaceutical industry
To improve the drug development process by supporting more efficient research and development cooperation among academia, SMEs and the biopharmaceutical industry
EU member states
H2020 associated countries
TOPICS
Open
– IMI2-2020-23-01: Returning Clinical Trial Data to study participants within a GDPR compliant and approved ethical framework
– IMI2-2020-23-02: Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistance
– IMI2-2020-23-03: A platform for accelerating biomarker discovery and validation to support therapeutics development for neurodegenerative diseases
– IMI2-2020-23-04: Optimal treatment for patients with solid tumours in Europe through Artificial Intelligence
– IMI2-2020-23-05: Shortening the path to Rare Disease diagnosis by using newborn genetic screening and digital technologies
– IMI2-2020-23-06: Behavioural Model of Factors Affecting Patient Adherence
* Budget per topic:
– IMI2-2020-23-01: 8.19 million euros
– IMI2-2020-23-02: 9.26 million euros
– IMI2-2020-23-03: 19.4 million euros
– IMI2-2020-23-04: 21.86 million euros
– IMI2-2020-23-05: 24.54 million euros
– IMI2-2020-23-06: 11.9 million euros
25 August 2021
